More recently, it was demonstrated that methylation of MAP3K2 by the cytosolic KMT SMYD3 promotes tumour formation through activation of the Ras-signalling pathway, establishing a role also for cytosolic lysine methylation in cancer [26]. This evidence concerns the gene MAP3K2 and neoplasm.